作者:Virginie Garcia、Pauline Le Faouder、Aude Dupuy、Thierry Levade、Stéphanie Ballereau、Yves Génisson
DOI:10.1002/cbdv.201400357
日期:2015.7
A new sphingolipid hybrid molecule was designed to assemble, within a tail-to-tail double-chain structure, the ceramide hydrophilic moiety and the tetrahydrofuran pharmacophore of jaspine B, a natural product known to interfere with sphingolipid metabolism. This compound was prepared through acylation of sphingosine with a jaspine B derivative bearing a COOH group in the terminal position of the aliphatic
设计了一种新的鞘脂杂合分子,以在尾到尾的双链结构中组装神经酰胺亲水部分和茉莉B的四氢呋喃药效基团,后者是已知会干扰鞘脂代谢的天然产物。该化合物是通过将鞘氨醇与在脂族主链的末端带有COOH基团的Jaspine B衍生物酰化而制备的。评价了这种新的杂合分子影响黑素瘤细胞活力和鞘脂代谢的能力。在保留神经酰胺本身的细胞毒性的同时,该化合物显示出降低鞘磷脂细胞水平并显着增强鞘氨醇-1-磷酸的产生,因此代表了一种新的鞘脂代谢调节剂。